Table 1.
Serum amyloid A and C-reactive protein levels in patients with diffuse systemic sclerosis and healthy controls.
Serum amyloid A (mg/mL) |
Serum C-reactive protein (mg/mL) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Median | LQ | UQ | dSSc subgroup versus controls |
Median | LQ | UQ | dSSc subgroup versus controls |
|||
p-value | Z-score | p-value | Z-score | |||||||
dSSc (n = 33) | 67.4 | 44.8 | 74.7 | 0.00013 | 3.8 | 47.7 | 12.8 | 197.6 | 0.00004 | 4.1 |
Early dSSc (n = 18) | 69.9 | 44.9 | 76.5 | 0.0004 | 3.5283 | 74.3 | 19.6 | 224.5 | 0.0003 | 3.5957 |
Late dSSc (n = 15) | 65.2 | 42.2 | 70.1 | 0.0013 | 3.2178 | 19.6 | 12.2 | 92.6 | 0.0002 | 3.7108 |
dSSc with ILD (n = 12) | 74.6 | 64.2 | 77.9 | 0.0005 | 3.4773 | 159.8 | 67.3 | 339.3 | 0.0005 | 3.4773 |
dSSc without ILD (n = 21) | 56.7 | 36.8 | 70.3 | 0.0009 | 3.3328 | 18.8 | 11.0 | 84.7 | 0.0002 | 3.7692 |
Controls (n = 11) | 21.4 | 6.8 | 28.7 | 2.5 | 1.7 | 28.7 |
dSSc, diffuse systemic sclerosis; ILD, interstitial lung disease; LQ, lower quartile; UQ, upper quartile.